Halsey Associates’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.59M Buy
46,709
+19,838
+74% +$721K 0.25% 56
2019
Q2
$1.1M Sell
26,871
-20,234
-43% -$803K 0.2% 59
2019
Q1
$1.9M Sell
47,105
-369
-0.8% -$14.8K 0.31% 52
2018
Q4
$1.97M Buy
47,474
+20,203
+74% +$839K 0.37% 50
2018
Q3
$1.14M Hold
27,271
0.2% 61
2018
Q2
$939K Sell
27,271
-20,730
-43% -$708K 0.18% 61
2018
Q1
$1.62M Sell
48,001
-1,158
-2% -$39.8K 0.28% 56
2017
Q4
$1.69M Buy
49,159
+19,887
+68% +$678K 0.29% 54
2017
Q3
$991K Buy
29,272
+844
+3% +$27.1K 0.2% 60
2017
Q2
$906K Sell
28,428
-6,272
-18% -$198K 0.19% 60
2017
Q1
$1.13M Buy
34,700
+1,139
+3% +$35.9K 0.24% 55
2016
Q4
$1.03M Sell
33,561
-707
-2% -$21.6K 0.23% 54
2016
Q3
$1.1M Buy
34,268
+693
+2% +$23.2K 0.24% 57
2016
Q2
$1.12M Sell
33,575
-2,992
-8% -$95.5K 0.25% 58
2016
Q1
$1.03M Sell
36,567
-7,877
-18% -$225K 0.23% 58
2015
Q4
$1.36M Buy
44,444
+109
+0.2% +$3.43K 0.31% 57
2015
Q3
$1.32M Hold
44,335
0.31% 55
2015
Q2
$1.41M Buy
44,335
+9,905
+29% +$323K 0.31% 49
2015
Q1
$1.14M Hold
34,430
0.25% 56
2014
Q4
$1.02M Buy
34,430
+23
+0.1% +$659 0.22% 61
2014
Q3
$965K Buy
34,407
+78
+0.2% +$2.19K 0.22% 62
2014
Q2
$967K Hold
34,329
0.21% 65
2014
Q1
$1.05M Sell
34,329
-292
-0.8% -$8.71K 0.24% 61
2013
Q4
$1.01M Hold
34,621
0.23% 64
2013
Q3
$944K Hold
34,621
0.23% 62
2013
Q2
$920K Buy
+34,621
New +$957K 0.24% 66

Other funds holding PFE

Halsey Associates's PFE Position: Q3 2019 in Review

Halsey Associates increased its Pfizer (PFE) stake by 74% in Q3 2019, buying an estimated $721K and bringing the position to 46,709 shares worth $1.59M. The position accounts for 0.25% of the portfolio, ranked #56.

Halsey Associates first reported a position in PFE in Q2 2013 and has held it in 26 quarters since. The position peaked at $1.97M in Q4 2018. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Halsey Associates held 46,709 shares of Pfizer worth $1.59M as of Q3 2019.
  • Halsey Associates bought 19,838 Pfizer shares in Q3 2019, an estimated $721K.
  • Pfizer made up 0.25% of Halsey Associates's portfolio in Q3 2019, its #56 holding.
  • Halsey Associates first reported a position in Pfizer in Q2 2013 and has held it in 26 quarters since.
  • Halsey Associates's Pfizer position peaked at $1.97M in Q4 2018.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Halsey Associates's 13F filing for Q3 2019, filed 15 Nov 2019.